| Andreas Peter Klemm Jr, PA-C | |
|
620 John Paul Jones Cir, Portsmouth, VA 23708-2111 | |
| (757) 953-5000 | |
| Not Available |
| Full Name | Andreas Peter Klemm Jr |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant - Medical |
| Location | 620 John Paul Jones Cir, Portsmouth, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154898591 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AM0700X | Physician Assistant - Medical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andreas Peter Klemm Jr, PA-C 3545 Norland Ct, Norfolk, VA 23513-4019 Ph: (757) 354-9436 | Andreas Peter Klemm Jr, PA-C 620 John Paul Jones Cir, Portsmouth, VA 23708-2111 Ph: (757) 953-5000 |
News Archive
Hi-Tech Pharmacal Co., Inc., a specialty pharmaceuticals company, announced today that the US Food and Drug Administration, (FDA) granted tentative approval for the Company's Abbreviated New Drug Application, (ANDA) for brimonidine tartrate with timolol maleate ophthalmic solution, the generic for Allergan's Combigan® ophthalmic solution which had sales of $108 million for the 12 months ended December 2010 according to IMS sales data.
The group led by Dr. George Georgiou developed the new antibody-production approach to improve upon processes used previously to identify new drugs.
Air-lifted trauma victims who received blood transfusions in the helicopter before arriving at a trauma center had higher one-day survival rates and less chance of shock than air-lifted patients who did not receive blood transfusions until they arrived at the trauma unit, according to study findings published online in the Journal of the American College of Surgeons.
Amira Pharmaceuticals, Inc. announced today that their collaborators, Andrew Tager, M.D. and Flavia V. Castelino, M.D. of Massachusetts General Hospital, Harvard Medical School, will present a preclinical proof-of-concept study which demonstrates that the bioactive lipid lysophosphatidic acid (LPA), through its high affinity LPA1 receptor, is an important mediator of fibrogenesis in the bleomycin mouse model of scleroderma. Data will be presented as part of a poster session for the 1st Systemic Sclerosis World Congress to be held in Florence, Italy, February 11 to 13, 2010.
› Verified 7 days ago
Mr. Michael A Shafer, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth Naval Hospital, Portsmouth, VA 23708 Phone: 757-953-9531 | |
Tobijah T Griffin, PHYSICIAN ASSISTANT Physician Assistant Medicare: Medicare Enrolled Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-1891 Fax: 757-953-7560 | |
Sara Elizabeth Snowden, P.A. Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 355 Crawford St, Suite 300, Portsmouth, VA 23704 Phone: 757-396-6333 Fax: 757-215-0177 | |
Jana Lentzner Galyo, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 3636 High St, Portsmouth, VA 23707 Phone: 757-398-2200 | |
Dennis B Mccarver, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-1245 | |
Cecelia D Rountree, Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Cir, Portsmouth, VA 23708 Phone: 757-953-5000 |